CRVO
Income statement / Annual
Last year (2025), CervoMed Inc's total revenue was $4.01 M,
and the percentage change from the previous year is not available.
In 2025, CervoMed Inc's net income was -$26.97 M.
See CervoMed Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$4.01 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$103.17 K
|
$97.92 K
|
$110.37 K
|
$67.98 K
|
$25.34 K
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$103.17 K
|
-$97.92 K
|
-$110.00 K
|
-$67.98 K
|
-$25.34 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$21.82 M
|
$18.80 M
|
$8.44 M
|
$1.34 M
|
$8.50 M
|
$9.43 M
|
$6.62 M
|
$5.75 M
|
$5.09 M
|
$6.25 M
|
| General & Administrative Expenses |
$10.48 M
|
$9.17 M
|
$6.52 M
|
$2.14 M
|
$7.45 M
|
$6.44 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.48 M
|
$9.17 M
|
$6.52 M
|
$2.14 M
|
$7.45 M
|
$6.44 M
|
$4.83 M
|
$6.17 M
|
$6.19 M
|
$8.59 M
|
| Other Expenses |
$0.00
|
-$9.74 M
|
-$7.14 M
|
$0.00
|
$8.73 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$32.30 M
|
$18.23 M
|
$7.81 M
|
$3.48 M
|
$24.68 M
|
$15.87 M
|
$11.45 M
|
$11.92 M
|
$11.28 M
|
$14.85 M
|
| Cost And Expenses |
$32.30 M
|
$18.23 M
|
$7.81 M
|
$3.48 M
|
$24.68 M
|
$15.98 M
|
$11.55 M
|
$12.03 M
|
$11.35 M
|
$14.87 M
|
| Interest Income |
$1.34 M
|
$1.94 M
|
$219.43 K
|
$62.23 K
|
$137.49 K
|
$114.26 K
|
$0.00
|
$151.65 K
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$587.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.92 M
|
$29.69 K
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$93.42 K
|
$103.17 K
|
$97.92 K
|
$110.37 K
|
$67.98 K
|
$25.34 K
|
| EBITDA |
-$28.29 M |
-$18.23 M |
-$7.81 M |
-$5.80 M |
-$15.94 M |
-$15.76 M |
-$11.37 M |
-$18.70 M |
$566.01 K |
-$18.35 M |
| EBITDA Ratio |
-7.06
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-7.06
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.33 M
|
$1.94 M
|
$5.64 M
|
-$2.33 M
|
$137.49 K
|
$114.25 K
|
$85.30 K
|
-$6.78 M
|
$8.93 M
|
-$3.53 M
|
| Income Before Tax |
-$26.97 M
|
-$16.29 M
|
-$2.17 M
|
-$5.80 M
|
-$24.54 M
|
-$15.86 M
|
-$11.47 M
|
-$18.81 M
|
-$2.42 M
|
-$18.40 M
|
| Income Before Tax Ratio |
-6.73
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$443.89 K
|
-$1.68 M
|
$332.89 K
|
-$437.00 K
|
-$1.06 M
|
-$365.00 K
|
| Net Income |
-$26.97 M
|
-$16.29 M
|
-$2.17 M
|
-$5.80 M
|
-$24.10 M
|
-$14.19 M
|
-$11.80 M
|
-$18.37 M
|
-$1.37 M
|
-$18.04 M
|
| Net Income Ratio |
-6.73
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-2.98 |
-2.02 |
-0.82 |
-11.2 |
-18.51 |
-22.5 |
-131.95 |
-424.93 |
-123.33 |
-1982.96 |
| EPS Diluted |
-2.98 |
-2.02 |
-0.82 |
-11.2 |
-18.51 |
-22.5 |
-131.95 |
-424.93 |
-120.35 |
-1982.96 |
| Weighted Average Shares Out |
$9.04 M
|
$8.07 M
|
$2.66 M
|
$518.14 K
|
$1.30 M
|
$717.76 K
|
$89.42 K
|
$43.23 K
|
$11.06 K
|
$9.10 K
|
| Weighted Average Shares Out Diluted |
$9.04 M
|
$8.07 M
|
$2.66 M
|
$518.14 K
|
$1.30 M
|
$717.76 K
|
$89.42 K
|
$43.23 K
|
$11.34 K
|
$9.10 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
